The Spectrum Brief
Autism research, in plain language
← Back to the feed

Diagnosis & ScreeningResearch

Emerging Biomarker Tests May Complement Autism Identification, With Key Limitations

From eye-tracking to stool analysis, research explores objective tools to identify autism traits earlier — though experts emphasize these may apply to specific subgroups and require more validation.

By The Spectrum Brief newsroom · 4 hours ago·Based on peer-reviewed research
Share

Expanding Options for Identification

Traditional autism identification has relied on behavioral observations, typically possible after age 2-3. Emerging research explores whether biological markers could provide additional insights. A 2024 study in Nature Communications examining gut microbiome metabolites found associations with certain autism subgroups, though the researchers note these may relate to co-occurring gastrointestinal patterns rather than autism itself. One experimental stool analysis tool received FDA Breakthrough Device designation — a status that accelerates regulatory review but does not confirm clinical effectiveness, as explained by the FDA.

Eye-tracking research also shows potential. A May 2024 JAMA Network Open study involving 350 infants found that specialized 20-minute eye-tracking protocols could help flag developmental differences. However, the authors caution this requires specific equipment and training not typically available in pediatric offices.

A May 2024 JAMA Network Open study involving 350 infants found that specialized 20-minute eye-tracking protocols could help flag developmental differences.

Digital Analysis Approaches

Some researchers are exploring whether technology can help analyze behavioral patterns. A 2023 Nature Medicine study trained algorithms on videos of children's play sessions in clinical settings, finding potential to identify certain developmental differences. This 'digital phenotyping' approach remains experimental and has only been tested in controlled research environments.

These diverse approaches share a goal of expanding identification options beyond current methods. Earlier recognition of developmental differences could help families access supportive services, though as a 2024 Frontiers in Psychiatry review notes, biomarker research must balance scientific potential with ethical considerations. Current AAP guidelines continue to recommend behavioral screening tools like the M-CHAT for routine developmental monitoring.

#biomarkers#earlydiagnosis#microbiome#eye-tracking#digitalphenotyping

Common questions

Share

Behind the brief

Adversarial editorial review

Approved70/100 consensus· 2 rounds

Open thread

Discussion

0 comments · The editorial board joins in. Be kind and cite sources where you can.

Loading comments…